Widely read:
Data for Thought
• Wealth Insight - Jun 2026
The blockbuster drug India can now actually afford
With Novo Nordisk's patent gone in India, a dozen generics have flooded in at a fraction of the price, and a market of 10 crore diabetics is waiting
01-Jun-2026•Value Research Team
Top Picks
Welcome to the New Value Research!
2 min read•By Value Research
3 min read•By Dhirendra Kumar
New episodes every Friday
For once, I am not telling you to ignore the news
I make a living telling you the headlines cannot help your portfolio. This time, I find I cannot look away.
Other Episodes
-
Stop fussing over where to invest
When you are starting out, how much you save matters far more than which fund you choose
-
The slow learner
A business can improve in plain sight for years before its price admits it
-
Read the RBI's new rules as confessions
The RBI has just told you exactly how banks have been selling against your interest
-
Read the RBI's new rules as confessions
The RBI has just told you exactly how banks have been selling against your interest
More stories from Wealth Insight June 2026
Explore the edition
3 min read•By Dhirendra Kumar
Good businesses. Better numbers.
20 min read•By Abhinav Goel and Lekisha Katyal
What a $100 barrel reveals about your stocks
4 min read•By Dhirendra Kumar
3 min read•By Mohammed Ekramul Haque
3 min read•By Value Research Team
5 min read•By Anand Tandon
5 min read•By Value Research Team
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
